{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:26:06Z","timestamp":1787833566100,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373105"],"award-info":[{"award-number":["82373105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the key research and development program of Jiangsu province","award":["BE2023834"],"award-info":[{"award-number":["BE2023834"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01582-z","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:15:12Z","timestamp":1787832912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalizing Postoperative Surveillance: A Risk-Stratified Predictive Model for Recurrence of Gastrointestinal Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"57","author":[{"given":"Zhangchao","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luohai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huae","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-9735","authenticated-orcid":false,"given":"Xiaolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"1582_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA oncol. 2017;3:1335\u201342.","journal-title":"JAMA oncol"},{"key":"1582_CR2","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","volume":"23","author":"BE White","year":"2022","unstructured":"White BE, Rous B, Chandrakumaran K, Wong K, Bouvier C, Van Hemelrijck M, et al. Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: A retrospective, population-based study. Lancet Reg Health Eur. 2022;23:100510.","journal-title":"Lancet Reg Health Eur"},{"key":"1582_CR3","doi-asserted-by":"publisher","first-page":"e13249","DOI":"10.1111\/jne.13249","volume":"35","author":"H Sorbye","year":"2023","unstructured":"Sorbye H, Grande E, Pavel M, Tesselaar M, Fazio N, Reed NS, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma. J Neuroendocrinol. 2023;35:e13249.","journal-title":"J Neuroendocrinol"},{"key":"1582_CR4","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1245\/s10434-022-11837-1","volume":"29","author":"E Merola","year":"2022","unstructured":"Merola E, Pascher A, Rinke A, Bartsch DK, Zerbi A, Nappo G, et al. Radical resection in entero-pancreatic neuroendocrine tumors: Recurrence-free survival rate and definition of a risk score for recurrence. Ann Surg Oncol. 2022;29:5568\u201377.","journal-title":"Ann Surg Oncol"},{"key":"1582_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/jso.27213","volume":"127","author":"Q Chen","year":"2023","unstructured":"Chen Q, Li K, Rhodin KE, Masoud SJ, Lidsky ME, Cai J, et al. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases. J Surg Oncol. 2023;127:945\u201355.","journal-title":"J Surg Oncol"},{"key":"1582_CR6","doi-asserted-by":"publisher","first-page":"930491","DOI":"10.3389\/fonc.2022.930491","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Ren H, Wang T, Zhang X, Zhao L, Sun C, et al. Resection of the primary tumor improves the survival of patients with stage IV gastric neuroendocrine carcinoma. Front Oncol. 2022;12:930491.","journal-title":"Front Oncol"},{"key":"1582_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172\u201385.","journal-title":"Neuroendocrinology"},{"key":"1582_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11864-017-0461-5","volume":"18","author":"M Cives","year":"2017","unstructured":"Cives M, Strosberg J. Treatment strategies for metastatic neuroendocrine tumors of the gastrointestinal tract. Curr Treat Options Oncol. 2017;18:14.","journal-title":"Curr Treat Options Oncol"},{"key":"1582_CR9","doi-asserted-by":"publisher","first-page":"102299","DOI":"10.1016\/j.ctrv.2021.102299","volume":"101","author":"R Broadbent","year":"2021","unstructured":"Broadbent R, Wheatley R, Stajer S, Jacobs T, Lamarca A, Hubner RA, et al. Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis. Cancer Treat Rev. 2021;101:102299.","journal-title":"Cancer Treat Rev"},{"key":"1582_CR10","doi-asserted-by":"publisher","first-page":"703138","DOI":"10.3389\/fsurg.2021.703138","volume":"8","author":"C Li","year":"2021","unstructured":"Li C, Zhang P, Sun X, Tong X, Chen X, Li C, et al. Risk factors and predictive score model for early recurrence after curative surgery in patients with poorly differentiated gastrointestinal neuroendocrine neoplasms. Front Surg. 2021;8:703138.","journal-title":"Front Surg"},{"key":"1582_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1467-9868.2011.00771.x","volume":"73","author":"Robert Tibshirani","year":"2011","unstructured":"Robert Tibshirani. Regression shrinkage and selection via the lasso: A retrospective. J R Stat Soc Ser B: Stat Methodol. 2011;73:273\u201382.","journal-title":"J R Stat Soc Ser B: Stat Methodol"},{"key":"1582_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1214\/08-AOAS169","volume":"2","author":"H Ishwaran","year":"2008","unstructured":"Ishwaran H, Kogalur UB, Blackstone EH, Lauer MH. Random survival forests. Ann Appl Stat. 2008;2:841\u201360.","journal-title":"Ann Appl Stat"},{"key":"1582_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152\u201360.","journal-title":"Ann Oncol"},{"key":"1582_CR14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","volume":"22","author":"LH Tang","year":"2016","unstructured":"Tang LH, Untch BR, Reidy DL, O\u2019Reilly E, Dhall D, Jih L, et al. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomas. Clin Cancer Res. 2016;22:1011\u20137.","journal-title":"Clin Cancer Res"},{"key":"1582_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, et al. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol. 2015;39:683\u201390.","journal-title":"Am J Surg Pathol"},{"key":"1582_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10120-020-01119-8","volume":"24","author":"H Zheng","year":"2021","unstructured":"Zheng H, Zhao Y, He Q, Hao H, Tian Y, Zou B, et al. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine\/mixed adenoneuroendocrine carcinoma. Gastric Cancer. 2021;24:503\u201314.","journal-title":"Gastric Cancer"},{"key":"1582_CR17","unstructured":"Li XA, Yao ZA, Liu YA, Fan JA, Xu H. Personalizing postoperative surveillance: A risk-stratified predictive model based on lasso-cox regression and random survival forest for postoperative progression of gastrointestinal neuroendocrine neoplasms. 23rd Annual ENETS conference for the diagnosis and treatment of neuroendocrine tumor disease. https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/jne.70163"},{"key":"1582_CR18","doi-asserted-by":"publisher","first-page":"e13306","DOI":"10.1111\/jne.13306","volume":"35","author":"F van Panzuto","year":"2023","unstructured":"Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J, Begum N, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. J Neuroendocrinol. 2023;35:e13306.","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"1582_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u201354.","journal-title":"Endocr Pathol"},{"key":"1582_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2105-9-307","volume":"9","author":"C Strobl","year":"2008","unstructured":"Strobl C, Boulesteix AL,Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinformatics. 2008;9:307.","journal-title":"BMC Bioinformatics"},{"key":"1582_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1159\/000539187","volume":"114","author":"S Liu","year":"2024","unstructured":"Liu S, Chen YX, Dai B, Chen L. Development and validation of a novel machine learning model to predict the survival of patients with gastrointestinal neuroendocrine neoplasms. Neuroendocrinology. 2024;114:733\u201348.","journal-title":"Neuroendocrinology"},{"key":"1582_CR22","first-page":"e24223","volume":"100","author":"S Xie","year":"2021","unstructured":"Xie S, Li L, Wang X, Li L. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Medicine(Baltimore). 2021;100:e24223.","journal-title":"Medicine(Baltimore)"},{"key":"1582_CR23","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1582_CR24","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.ejso.2014.06.016","volume":"40","author":"S Singh","year":"2014","unstructured":"Singh S, Hallet J, Rowsell C, Law CH. Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease. Eur J Surg Oncol. 2014;40(11):1517\u201322.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"1582_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000439434","volume":"103","author":"F Grillo","year":"2016","unstructured":"Grillo F, Albertelli M, Brisigotti MP, et al. Grade increases in gastroenteropancreatic neuroendocrine tumor metastases compared to the primary tumor. Neuroendocrinology. 2016;103(5):452\u20139.","journal-title":"Neuroendocrinology"},{"issue":"10","key":"1582_CR26","doi-asserted-by":"publisher","first-page":"e13193","DOI":"10.1111\/jne.13193","volume":"34","author":"E Merola","year":"2022","unstructured":"Merola E, Perren A, Rinke A, et al. High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent. J Neuroendocrinol. 2022;34(10):e13193.","journal-title":"J Neuroendocrinol"},{"key":"1582_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond). 2020;40:301\u201312.","journal-title":"Cancer Commun (Lond)"},{"key":"1582_CR28","doi-asserted-by":"publisher","first-page":"949500","DOI":"10.3389\/fpubh.2022.949500","volume":"10","author":"B Gao","year":"2022","unstructured":"Gao B, Wang MD, Li Y, Huang F. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection. Front Public Health. 2022;10:949500.","journal-title":"Front Public Health"},{"key":"1582_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cam4.3613","volume":"10","author":"B Yan","year":"2021","unstructured":"Yan B, Su BB, Bai DS, Qian JJ, Zhang C, Jin SJ. Jiang GQ.A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma. Cancer Med. 2021;10:496\u2013506.","journal-title":"Cancer Med"},{"issue":"1","key":"1582_CR30","doi-asserted-by":"publisher","first-page":"19103","DOI":"10.1038\/s41598-024-70349-y","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Chen H, Wu Y, Jiang T, Wang X, Zheng J, Lin X. Novel nomogram and risk stratification for peritoneal recurrence after curative resection in gastric cancer. Sci Rep. 2024;14(1):19103.","journal-title":"Sci Rep"},{"key":"1582_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000443172","volume":"103","author":"R Garcia-Carbonero","year":"2016","unstructured":"Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B et al. Consensus Conference participants (2016). ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103:186\u2013194.","journal-title":"Neuroendocrinology"},{"issue":"7","key":"1582_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844\u201360.","journal-title":"Ann Oncol"},{"key":"1582_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","volume":"46","author":"JR Strosberg","year":"2017","unstructured":"Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, et al. The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors. Pancreas. 2017;46:707\u201314.","journal-title":"Pancreas"},{"key":"1582_CR34","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jamaoncol.2018.2428","volume":"4","author":"S Singh","year":"2018","unstructured":"Singh S, Moody L, Chan DL, Metz DC, Strosberg J, Asmis T, et al. Commonwealth neuroendocrine tumour collaboration (CommNETS) follow-up working group. Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. JAMA Oncol. 2018;4:1597\u2013604.","journal-title":"JAMA Oncol"},{"key":"1582_CR35","doi-asserted-by":"publisher","first-page":"e27302","DOI":"10.1097\/MD.0000000000027302","volume":"100","author":"S Liu","year":"2021","unstructured":"Liu S, Ge X, Gao Z, Zhou Q, Shi Y, Jiang W, et al. Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis. Medicine. 2021;100:e27302.","journal-title":"Medicine"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01582-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01582-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01582-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:15:14Z","timestamp":1787832914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01582-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01582-z","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Due to the low-risk nature of this study, the ethics committee waived informed consent. This study has been approved by the Ethics Committee of The First Affiliated Hospital with Nanjing Medical University.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing interests to declare.","order":3,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"199"}}